|
|
|
|
|
|
|
|
|
|
|
|
| Nr. |
Autoren |
|
Titel |
|
|
|
|
|
|
|
|
|
|
|
|
| P01 |
Barmaverain D, Hasler S, Kalbermatten C |
|
Oxidation during fresh plants processing – A race against time |
|
|
|
|
|
|
|
|
|
|
|
|
| P02 |
Bachmann C, Peter S, Meier B, Lardos A |
|
Vergleich und Optimierung einer neuen HPLC-Gehaltsbestimmung für Frangluae cortex in der Ph. Eur. |
|
|
|
|
|
|
|
|
|
|
|
|
| P03 |
Hänni M, Peter S, Wolfram E, Meier B |
|
Evaluation and optimization of HPTLC and assay methods for Aurantii amari flos and Aurantii dulcis flos |
|
|
|
|
|
|
|
|
|
|
|
|
| P04 |
Peter S, Abdelmalek B, Meier B, Wolfram E |
|
HPTLC identity testing for Rhamni purshianae cortex |
|
|
|
|
|
|
|
|
|
|
|
|
| P05 |
Saladin J, Urech S, Chundattu A, Weiss N, Adlhart C, Baier A |
|
Corn storage protein zein: Biopolymer for drug delivery systems |
|
|
|
|
|
|
|
|
|
|
|
|
| P06 |
Lorenz F, Falch B |
|
Konzept zur Erstellung einer Datenbank mit dem Ziel, phytotherapeutische Rezepturen für Gesundheitsfachpersonen zugänglich zu machen |
|
|
|
|
|
|
|
|
|
|
|
|
| P07 |
Abegg VF, Spiess D, Chaveau A, Treyer A, Duong E, Oufir M, Potterat O, Simões-Wüst P A, Hamburger M |
|
Phytomedicines for mental disease and the placental barrier – an ex vivo study |
|
|
|
|
|
|
|
|
|
|
|
|
| P08 |
Hoerr R, Zimmermann A, Dienel A |
|
Single and repeated doses of Ginkgo biloba extract EGb 761 ® do not affect pharmacokinetics and pharmacodynamics of rivaroxaban in healthy volunteers |
|
|
|
|
|
|
|
|
|
|
|
|
| P09 |
Haßler S, Jung K, Kelber O, Feistel B, Steinhoff B, Nieber K |
|
Assessment of the genotoxic safety of herbal drug preparations used for constipation |
|
|
|
|
|
|
|
|
|
|
|
|
| P10 |
Mitchell A C, Embry R M, Gafner S, Johnson H, Marsman S D, Kelber O, Oketch-Rabah A H, Rider V C, Sudberg E, Welch C |
|
Enhancing the botanical safety toolkit: The strategy of the Botanical Safety Consortium |
|
|
|
|
|
|
|
|
|
|
|
|
| P11 |
Löbel K, Garfield S, Heinrich M |
|
Perceiving quality, efficacy and safety of herbal medicines in Chile |
|
|
|
|
|
|
|
|
|
|
|
|
| P12 |
Stange R, Albrecht U |
|
Juniper berry oil in the treatment of gastrointestinal disturbances |
|
|
|
|
|
|
|
|
|
|
|
|
| P13 |
Brecht Brüngger K, Mettler L, Butterweck V, Meyer zu Schwabedissen H |
|
Effect of Petasites hybridus extract Ze 339 on organic cation transporter 3 – consequences for intestinal handling of histamine |
|
|
|
|
|
|
|
|
|
|
|
|
| P14 |
Buczkowski A, Welzel P H, Strätling J E, Bereswill S, Heimesaat M M, Melzig F M, Schmidt S |
|
Role of calcium in the eugenol-mediated reduction of tobramycin resistance in Pseudomonas aeruginosa |
|
|
|
|
|
|
|
|
|
|
|
|
| P15 |
Bussmann H, Häberlein H, Boonen G, Franken S |
|
Influence of St. John’s wort extract Ze 117 on the lateral mobility of β 1 - adrenergic receptors in C6 cells |
|
|
|
|
|
|
|
|
|
|
|
|
| P16 |
Bussmann H, Häberlein H, Boonen G, Butterweck V, Franken S |
|
Low hyperforin St. John’s wort extract Ze 117 counteracts the cortisol mediated chain length extension and increased number of double bonds in phospholipids of PBMC |
|
|
|
|
|
|
|
|
|
|
|
|
| P17 |
Cameron S, Napp J, Kuchta K, Rausch H, Ellenrieder V |
|
Effekte von Gemcitabin und einem Arzneipflanzenextrakt der japanischen Kampo-Medizin in einem Pankreaskarzinom-Mausmodell |
|
|
|
|
|
|
|
|
|
|
|
|
| P18 |
Cha H, Sittek M L, Schmidts M T, Schlupp P |
|
Ingredients of isla® medic acting as physical barrier for the prevention and treatment of the rhinovirus infection |
|
|
|
|
|
|
|
|
|
|
|
|
| P19 |
Gündling PW |
|
Eine Zistrosenvarietät als potentieller Schutz vor SARS-CoV-2 und seinen Varianten |
|
|
|
|
|
|
|
|
|
|
|
|
| P20 |
Günther M, Rabenau M, Drewe J, Boonen G, ButterweckV, Culmsee C |
|
Cimicifuga racemosa extract targets mitochondrial metabolism by suppressing TCA-cycle dependent substrate utilization |
|
|
|
|
|
|
|
|
|
|
|
|
| P21 |
Günther M, Drewe J, Boonen G, Butterweck V, Culmsee C |
|
Cimicifuga racemosa extract Ze 450 mitigates UVB-induced oxidative damage in mouse embryonic fibroblasts |
|
|
|
|
|
|
|
|
|
|
|
|
| P22 |
Hedden M, Pausan M, Kelber O, Kolb C |
|
Johanniskraut – beeinflussen Flavonoide die Darmflora? |
|
|
|
|
|
|
|
|
|
|
|
|
| P23 |
Jaklin M, Röhrl J, Pique-Borras R M, Ammendola A, Künstle G |
|
Euphrasia planta tota extract revealed a variety of anti-inflammatory properties |
|
|
|
|
|
|
|
|
|
|
|
|
| P24 |
Kelber O, Khayyal M T |
|
Influence of the microbiota on the phytochemical constituents of natural products and vice versa – metabolomic approaches |
|
|
|
|
|
|
|
|
|
|
|
|
| P25 |
Pferschy-Wenzig M E, Pausan R M, Ardjomand-Wölkart K, Röck S, Ammar R M, Kelber O, Moissl-Eichinger C, Bauer R |
|
Arzneipflanzen und ihre Wirkung auf die psychische Gesundheit: Welche Rolle spielt das Darmmikrobiom? |
|
|
|
|
|
|
|
|
|
|
|
|
| P26 |
Khayyal MT, Meselhy R M, El-Baz K F, El Hazek M R |
|
Extracts of Dunaliella salina, a microalga, protect against radiation-induced intestinal mucositis |
|
|
|
|
|
|
|
|
|
|
|
|
| P27 |
Khayyal MT, Gamal N, Mohsen R |
|
The efficacy of STW 5 in irritable bowel syndrome partly involves serotonin as a mediator in the brain-gut axis |
|
|
|
|
|
|
|
|
|
|
|
|
| P28 |
Khayyal MT, Abdel-Wahab N, El-Sayed S, Aziz-Kalbhenn H |
|
The herbal preparation STW 5 is effective in functional dyspepsia at least partly by beneficially affecting changes in the microbiome |
|
|
|
|
|
|
|
|
|
|
|
|
| P29 |
Kuchta K, Cameron S |
|
Phytotherapie bei Kachexie: Pharmakologische Targets |
|
|
|
|
|
|
|
|
|
|
|
|
| P30 |
Kuchta K, Cameron S, Shoyama Y |
|
Which East Asian herbal medicines can decrease viral infections? |
|
|
|
|
|
|
|
|
|
|
|
|
| P31 |
Lejri I, Grimm A, Eckert A |
|
Ginkgo biloba extract increases neurite outgrowth and activates the Akt/mTOR pathway |
|
|
|
|
|
|
|
|
|
|
|
|
| P32 |
Mangoato IM, Shcherbakova A, Matsabisa G M, Ulrich-Merzenich G |
|
A network pharmacology-based study on the molecular mechanisms of the active ingredients of Cannabis sativa L. against multidrug resistance in cervical cancer |
|
|
|
|
|
|
|
|
|
|
|
|
| P33 |
Meurer F, Schulte-Michels J, Häberlein H, Franken S |
|
Ivy leaves dry extract EA 575 ® enhances G protein/cAMP pathway and simultaneously inhibits GRK2/β-arrestin 2 pathway leading to a biased β2-adrenergic receptor signaling |
|
|
|
|
|
|
|
|
|
|
|
|
| P34 |
Stute P, Ehrentraut S, Henneicke-von Zepelin H,
Nicken P |
|
Gene expression analyses support multi-target mode of action of black cohosh (Cimicifuga racemosa) against menopausal complaints |
|
|
|
|
|
|
|
|
|
|
|
|
| P35 |
Röhrl J, Jaklin M, Piqué-Borràs R M, Ammendola A, Künstle G |
|
Arnica planta tota is superior to Arnica flos with regard to anti-inflammatory properties |
|
|
|
|
|
|
|
|
|
|
|
|
| P36 |
Fumagalli M, Paladino G, Piazza S, Rossini N, Ciriello U, Magnavacca A, Martinelli G, Pozzoli C, Dell’Agli M, Sangiovanni E |
|
Cannabidiol has a central role in the NF-κB inhibition of a Cannabis sativa L. extract in human keratinocytes |
|
|
|
|
|
|
|
|
|
|
|
|
| P37 |
Sakr H, Schmidt S, Bereswill S, Heimesaat M M, Melzig F M |
|
Antibiotika-Recycling: Resistenzmodifikation durch Naturstoffe |
|
|
|
|
|
|
|
|
|
|
|
|
| P38 |
Vimalanathan S, Schoop R, Pleschka S |
|
Broad antiviral effects of Echinacea purpurea against SARS-CoV-2 variants of concern and potential mechanism of action |
|
|
|
|
|
|
|
|
|
|
|
|
| P39 |
Shcherbakova A, Kelber O, Ammar R, Ulrich-Merzenich G |
|
Identifizierung und Regulierung gemeinsamer molekularer Targets des Reizdarmsyndroms und von STW 5-II |
|
|
|
|
|
|
|
|
|
|
|
|
| P40 |
Schiller L, Hammoud Mahdi D, Lipowicz B, Vissiennon C |
|
Synergismus in der Phytotherapie – Pharmakologische Interaktionen eines Kombinationsarzneimittels aus Myrrhe, Kamillenblüten und Kaffeekohle |
|
|
|
|
|
|
|
|
|
|
|
|
| P41 |
Kolev E, Johnston L S, Stange R, Gancitano G, Weishaupt R, Kreft S |
|
Echinacea purpurea for the long-term prevention of viral respiratory tract infections during COVID-19 pandemic: A randomized, open, controlled clinical study |
|
|
|
|
|
|
|
|
|
|
|
|
| P42 |
Santos S, Zurfluh L, Mennet M, Potterat O, von Mandach U, Hamburger M, Simões-Wüst P A |
|
Bryophyllum pinnatum compounds inhibit oxytocin-induced signalling pathways in human myometrial cells |
|
|
|
|
|
|
|
|
|
|
|
|
| P43 |
Mischer N, Kelber O, Raskopf E, Frohne I, Richter G J, Nieber K |
|
Phytotherapie bei Schmerzen: Daten aus der PhytoVIS-Studie, einer NIS bei 20.870 Anwendern pflanzlicher Arzneimittel |
|
|
|
|
|
|
|
|
|
|
|
|
| P44 |
Schmitt J, Schneider K, Kelber O, Bonaterra A G, Müller J, Kinscherf R |
|
Phytohustil and root extract of marshmallow Althaea officinalis L. exert anti-inflammatory and anti-oxidative properties and improve the migratory capacity of HUVECs tested in an in vitro model of angiogenesis |
|
|
|
|
|
|
|
|
|
|
|
|
| P45 |
Volz H-P, Klement S |
|
Influence of Silexan on functional impairment in patients with anxiety disorders – an analysis of pooled data |
|
|
|
|
|
|
|
|
|
|
|
|
| P46 |
Rotmann R A, Mordhorst N, Kassen A |
|
Damiana (Turnera diff usa Willd.) bei vermindertem sexuellen Verlangen – Ergebnisse einer prospektiven, multizentrischen Beobachtungsstudie |
|
|
|
|
|
|
|
|
|
|
|
|
| P47 |
Nicolussi S, Ardjomand-Woelkart K, Stange R, Gancitano G, Klein P, Ogal M |
|
Echinacea as a potential force against coronavirus infections? |
|
|
|
|
|
|
|
|
|
|
|
|
| P48 |
Pelzer F, Loef M, Martin D D, Baumgartner S |
|
Behandlung der Tumor-assoziierten Fatigue mit Mistelextrakten: Eine systematische Übersichtsarbeit und Metaanalyse |
|
|
|
|
|
|
|
|
|
|
|
|
| P49 |
Schandry R, Kaiser J, Mauz M |
|
Elevation of blood pressure in moderate hypotension through a Camphor and Crataegus combination is accompanied by an increase of cognitive functions |
|
|
|
|
|
|
|
|
|
|
|
|
| P50 |
Schmidt M |
|
Accelerated wound healing with comfrey herb cream |
|
|
|
|
|
|
|
|
|
|
|
|
| P51 |
Schmidt M, Hülsmann O |
|
Carmelite Spirit: Effi cacious and more than just ethanol in the treatment of upper respiratory tract infections |
|
|
|
|
|
|
|
|
|
|
|
|
| P52 |
Suleiman M, Luay Rashan L |
|
Case report of patient with gliosarcoma treated with surgery, radio-chemotherapy and Boswellia sacra preparation |
|
|
|
|
|
|
|
|
|
|
|
|
| P53 |
Szabela D, Tokarska J, Żyłka J, Paprot E, Litwin M, Darda-Ledzion L |
|
Chinese herbal medicine aided to rehabilitation after stroke and after trauma brain injury. Cases report |
|
|
|
|
|
|
|
|
|
|
|
|
| P54 |
Weishaupt R, Kolev E, Klein P, Schoop R |
|
Reduction of viral load in patients with acute sore throats: Results from an observational clinical trial with Echinacea/Salvia lozenges |
|
|
|
|
|
|
|
|
|
|
|
|
| P55 |
Zürcher BF |
|
Die Tibetische Rezeptur cong zhi 6 (Padma Aciben / Padma AciTib) in der HNO-Praxis: Erfahrungen bei laryngopharyngealem Refl ux (LPR) |
|
|
|
|
|
|
|
|
|
|
|
|
| P56 |
Kraft K, Böttcher C, Janik H |
|
Phytotherapie: Vorkenntnisse und Interesse bei Medizinstudierenden der Universitätsmedizin Rostock |
|
|
|
|
|
|
|
|
|
|
|
|
| P57 |
Kelber O, Raskopf E, Lindner A, Möller J, Nieber K, Grundmann O |
|
Comparison of epidemiological data on functional GI diseases under an herbal therapy from non-interventional studies in the US and Germany |
|
|
|
|
|
|
|
|
|
|
|
|
| P58 |
Rutishauser M |
|
Medicinal and galactagogue plants in the postpartum period |
|
|
|
|
|
|
|
|
|
|
|
|
| P59 |
Dal Cero M, Pinto D, Vennos C |
|
Plastizität Tibetischer Rezepturen und botanische Variabilität der Wirkstoff e gemäß dem Verständnis der Tibetischen Medizin am Beispiel der Rezepturfamilie Padma 28 |
|
|
|
|
|
|
|
|
|
|
|
|
| P60 |
Dal Cero M, Saller R, Weckerle S C |
|
Schafgarbe, Andorn und Vogelknöterich: Drei Arzneipflanzen und ihr wechselvolles „Schicksal“ in der Pflanzenheilkunde |
|
|
|
|
|
|
|
|
|
|
|
|
| P61 |
Christen-Clottu O, Biegel U, Reif M |
|
Fallserie zur oralen Verwendung eines Mistelextraktes (Viscum album L.) beim equinen Sarkoid |
|
|
|
|
|
|
|
|
|
|
|
|
| P62 |
Felenda JE, Graf-Schiller S, Turek C, Stintzing C F |
|
The use of mistletoe preparations to treat equine sarcoids |
|
|
|
|
|
|
|
|
|
|
|
|
| P63 |
Schlittenlacher T, Maeschli A, Walkenhorst M |
|
Ethnoveterinary use of medicinal plants in the treatment of small ruminants – a survey in Bavaria |
|
|
|
|
|
|
|
|
|
|
|
|
| P64 |
Walkenhorst M, Meier B, Hamburger M |
|
Klauenerkrankungen mit Arzneipflanzen behandeln – ethnoveterinärmedizinische Forschungsergebnisse aus der Schweiz |
|
|
|
|
|
|
|
|
